News >

Immunotherapy Generates Excitement in Gastric/GEJ Cancers

Kristi Rosa
Published: Saturday, Jun 08, 2019

S. Lindsey Davis, MD

S. Lindsey Davis, MD

Immunotherapy is an exciting area of ongoing research in gastric and gastroesophageal junction (GEJ) cancer, said S. Lindsey Davis, MD, but investigators still need to identify in which setting and for which patient subsets this approach will be most beneficial.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication